Addenda Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.09M Buy
+131,582
New +$759K 0.03% 123
2020
Q1
– Sell
-8,558
Closed -$258K – 96
2019
Q4
$258K Buy
+8,558
New +$222K 0.02% 102
2019
Q3
– Sell
-8,558
Closed -$216K – 109
2019
Q2
$216K Buy
+8,558
New +$203K 0.02% 112
2015
Q4
– Sell
-2,120
Closed -$377K – 126
2015
Q3
$377K Sell
2,120
-140
-6% -$32.6K 0.04% 117
2015
Q2
$502K Buy
2,260
+190
+9% +$42.1K 0.04% 116
2015
Q1
$409K Sell
2,070
-1,193
-37% -$212K 0.03% 118
2014
Q4
$468K Buy
3,263
+1,193
+58% +$160K 0.04% 118
2014
Q3
$272K Sell
2,070
-212,120
-99% -$25.3M 0.02% 130
2014
Q2
$27.1M Buy
214,190
+21,500
+11% +$2.74M 2.3% 11
2014
Q1
$25.4M Sell
192,690
-8,200
-4% -$1.12M 2.28% 11
2013
Q4
$23.6M Sell
200,890
-3,200
-2% -$351K 2.1% 12
2013
Q3
$21.3M Buy
204,090
+11,130
+6% +$1.08M 1.96% 16
2013
Q2
$16.6M Buy
+192,960
New +$15.2M 1.62% 18

Other funds holding BHC

Addenda Capital's BHC Position: Q3 2026 in Review

Addenda Capital opened a new position in Bausch Health (BHC) in Q3 2026: 131,582 shares worth $1.09M. The stake represents 0.03% of the portfolio and ranks #123 among its holdings. This is a return to the name: Addenda Capital previously reported a position in BHC as recently as Q4 2019.

Addenda Capital first reported a position in BHC in Q2 2013 and has held it in 13 quarters since. The position peaked at $27.1M in Q2 2014. 112 funds tracked by Wall St. Rank hold BHC as of Q3 2026.

  • Addenda Capital held 131,582 shares of Bausch Health worth $1.09M as of Q3 2026.
  • Bausch Health was a new Addenda Capital position in Q3 2026.
  • Bausch Health made up 0.03% of Addenda Capital's portfolio in Q3 2026, its #123 holding.
  • Addenda Capital first reported a position in Bausch Health in Q2 2013 and has held it in 13 quarters since.
  • Addenda Capital's Bausch Health position peaked at $27.1M in Q2 2014.
  • 112 funds tracked by Wall St. Rank held Bausch Health as of Q3 2026.

Based on Addenda Capital's 13F filing for Q3 2026, filed 13 Oct 2026.